Active ingredients: ribavirin
What it is used for
COPEGUS is indicated in combination with PEGASYS (peginterferon alfa-2a) or other interferon alfa agents for the treatment of chronic hepatitis C in previously untreated (treatment-naive) patients. COPEGUS in combination with PEGASYS is also indicated for the treatment of patients who have failed preivous treatment with interferon alfa (pegylated or non-pegylated) alone or in combination therapy with ribavirin. COPEGUS is also indicated in combination with PEGASYS for the treatment of chronic hepatitis C in patients with clinically stable human immunodeficiency virus (HIV) who have previously not received interferon therapy. Patients must be 18 years of age or older and have compensated liver disease.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Lifetime is 4 Years.
Always read the label. If symptoms persist see your healthcare professional.
Light pink to pink, flat, oval film-coated tablets with "RIB" & "200" engraved on one side and "ROCHE" on the other.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
Is this medicine subsidised?
This medicine may be subsidised which may make it cheaper. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient ribavirin
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.